Source:http://linkedlifedata.com/resource/pubmed/id/17689620
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2007-8-10
|
pubmed:abstractText |
This is the first case of a 65 year old healthy woman developing de novo mental confusion during treatment with 2 mg tolterodine twice daily. It is a rare complication of therapy for overactive bladder and resolved when dosage was reduced to 1 mg, although overactive bladder symptoms were still controlled.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
1097-6868
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
197
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
e8
|
pubmed:meshHeading |
pubmed-meshheading:17689620-Aged,
pubmed-meshheading:17689620-Benzhydryl Compounds,
pubmed-meshheading:17689620-Cognition Disorders,
pubmed-meshheading:17689620-Cresols,
pubmed-meshheading:17689620-Female,
pubmed-meshheading:17689620-Humans,
pubmed-meshheading:17689620-Phenylpropanolamine,
pubmed-meshheading:17689620-Urinary Bladder, Overactive
|
pubmed:year |
2007
|
pubmed:articleTitle |
Cognitive dysfunction with tolterodine use.
|
pubmed:affiliation |
Department of Obstetrics and Gynecology, University of Insubria, Del Ponte Hospital, Varese, Italy. stefanosalvatore@hotmail.com
|
pubmed:publicationType |
Journal Article,
Case Reports
|